Reference
Lin L, et al. Response to afatinib in a patient with non-small cell lung cancer harboring HER2 R896G mutation: A case report. OncoTargets and Therapy 12: 10897-10902, 12 Dec 2019. Available from: URL: http://doi.org/10.2147/OTT.S228726
Rights and permissions
About this article
Cite this article
Afatinib. Reactions Weekly 1787, 21 (2020). https://doi.org/10.1007/s40278-020-73659-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-73659-z